Biocryst is offloading part of its business for $250 million. Meanwhile, the former FDA leader took issue with a new policy for COVID-19 shots.

Peter Marks, MD, PhD, director of FDA's Center for Biologics Evaluation and Research (CBER), strongly refuted claims made by Joseph Ladapo, MD, PhD, that the vaccines may be contaminated with DNA ...

A former Deputy National Chairman of the Peoples Democratic Party (PDP), Chief Olabode George, has criticized the trio of ...

Pope Leo XIV is marking a feast day as the Vatican launches a new campaign to boost donations from the faithful. Leo ...

Pope Leo XIV on Sunday celebrated a special feast day traditionally used by the Catholic Church to drum up donations from the ...

The black-and-white thinking in our politics brings to mind a skill that the state of Texas requires me to teach my college ...

The abrupt departure of Peter Marks as the director of the FDA's Centre for Biologics Evaluation and Research (CBER), citing irreconcilable differences with new Health and Human Services Secretary ...

The Rays have signed right-hander Peter Strzelecki to a minor league deal, MLBTR's Tim Dierkes reports.  Strzelecki was just released ...

Princess Andre celebrated turning 18th with a glamorous photoshoot shared on Sunday to mark the special milestone.The budding ...

Leo celebrated Mass in St. Peter’s Basilica, marking the Feast of Saints Peter and Paul, during which he gave the pallium woolen stole to 54 new archbishops.

Dr Peter Marks, director of the FDA Center for Biologics Evaluation and Research told a packed house in San Francisco for JPM that FDA wants to support gene therapies in 2024.

In June 2024, Peter Marks, MD, PhD, then director of the FDA's Center for Biologics Evaluation and Research, unilaterally gave final expanded approval to Elevidys for DMD.